CD14 and neoplasm: Cocultures of human CD14+ MDMs with tumor cells in the presence of supernatants collected from decoy-engineered T cell cultures (Figure 4A) revealed significantly higher phagocytic activity for CV1-Fc than wtSiRPα-Fc (Figure 4B), and supernatants from CV1-Fc–engineered T cells had a similar impact on phagocytosis regardless of whether or not the T cells were coengineered to express the A97L-TCR (Supplemental Figure 4F).